Creating Secure Medicine Return Programs to Reduce Misuse of Medicines in King County & Washington State
|
|
- Amie Harper
- 10 years ago
- Views:
Transcription
1 WEST VIRGINIA INTEGRATED BEHAVIORAL HEALTH CONFERENCE Creating Secure Medicine Return Programs to Reduce Misuse of Medicines in King County & Washington State Margaret Shield, PhD, Policy Liaison Local Hazardous Waste Management Program in King County (WA) September 17, 2013
2 Local Hazardous Waste Management Program in King County (LHWMP) Program Partners: Public Health - Seattle & King County King Co. Water and Land Resources Division King Co. Solid Waste Division Seattle Public Utilities Sound Cities Association Medicine Take-Back Activities since 2005 Promoting programs: pilots, models, technical & financial assistance Education on safe storage & disposal Working on Local, State & Federal policy initiatives 2
3 Overview of Today s Presentation Secure medicine return & Preventing medicine abuse, poisonings, and overdose deaths Voluntary medicine take-back programs & Barriers to a comprehensive system Recent action by King County Board of Health to adopt the Secure Medicine Return Regulations Explanation of Product Stewardship Approach Walk-through the Regulations requirements Q&A 3
4 Secure Medicine Return Problem Statement Drug overdose deaths have surpassed car crashes as a leading cause of preventable death in King County. Medicines used in the home are the leading cause of poisonings, especially among children and seniors. Medicine take-back programs provide secure collection and destruction of unwanted medicines to protect public health and the environment. Currently, no sustainable financing for a medicine take-back system that meets community needs. 4
5 Epidemic: Responding to America s Prescription Drug Abuse Crisis 2013 National Drug Control Strategy: 1. Education of health providers and the public. 2. Expand prescription monitoring programs. 3. Safe drug disposal increase return/take-back and disposal programs. 4. Effective enforcement to address pill mills and doctor shopping. 5
6 What are the options for disposal? Flushing Medications: 20-33% of people still flush medications Sewer systems not designed to treat pharmaceuticals Studies find medicines in Puget Sound Throwing Medications in the Trash: Trash cans are not secure Medicines enter the environment via landfill leachate Businesses are not allowed to put medicines in the trash 6
7 Voluntary Medicine Take-Back Programs Secure AND environmentally sound Some Law Enforcement Some Pharmacies Secure Tracking & Storage Safe Disposal by High Temperature Incineration 7
8 Barriers to a Comprehensive Medicine Take-back System in King County: Challenges in collection of controlled substances help coming from new DEA draft regulation! authorizes take-back by retail pharmacies, manufacturers, drug distributors, and reverse distributors. Convenience and access too few drop-off sites; too much of county unserved. Financing lack of dedicated & adequate funding; very limited funding for education & promotion. Lack of an efficient system no county-wide coordination. 8
9 DEA s Proposed Rule for Secure & Responsible Drug Disposal Act of 2010 December 2012 draft rule published; comment period ended February Waiting for final rule. Controlled substances may be collected with all other medicines through 3 take-back methods under specific security protocols. Collection receptacles (i.e. drop-off boxes) and mailback programs may be operated by authorized retail pharmacies, drug manufacturers, drug distributors, reverse distributors, and law enforcement. Take-back events may be conducted by law enforcement only. 9
10 King County Board of Health Legislative body that sets county-wide policies and regulations to protect and promote the health of King County residents. Board Chair Councilmember Joe McDermott Boardmember Mayor David Baker Subcommittee on Secure Medicine Return Board Chair Joe McDermott, Boardmembers David Baker, Richard Conlin and Dr. Bud Nicola, and Public Health Director David Fleming July October 2012, collected stakeholder input (pro & con). October April 2013, policy discussions Public hearings held May 16 th and June 20 th, 2013 Secure Medicine Return Regulations adopted on June 20, Effective July 20,
11 Board of Health Subcommittee on Secure Medicine Return Stakeholders included: Current providers or regulators of medicine take-back activities Pharmaceutical industry Organizations representing impacted residents Substance abuse professionals Health and medical organizations Community organizations Environmental groups 11
12 Product Stewardship Approaches for Medicine Take-back Pharmaceutical manufacturers provide medicine return systems in B.C., Manitoba, Ontario, France, Spain & Mexico. Product stewardship is the act of minimizing health, safety, environmental, social impacts, while maximizing economic benefits of a product and its packaging throughout all lifecycle stages. and 12
13 Government Oversight 13
14 Examples of Producer Take-Back Programs for Other Hazardous Products Rechargeable Batteries Paint Electronic Waste Auto Switches Mercury Lighting & Thermostats Cell Phones 14
15 Product Stewardship Legislation for Pharmaceuticals in the U.S. Federal legislation introduced in 2011 (HR 2939 Slaughter); no action taken; potential reintroduction in 2013 or State-level legislation proposed in 8 states in recent years (CA, FL, ME, MD, MN, NY, OR, PA, WA); none have passed yet. San Francisco, City & County, considered Safe Drug Disposal ordinance in Legislation tabled when PhRMA and Genentech agreed to grant funds for a city-operated pilot program. Alameda County, CA passed a Safe Drug Disposal Ordinance in July Pharma associations sue. 15
16 Secure Medicine Return Regulations Adopted by King County Board of Health - Overview Drug producers are required to finance and provide the secure medicine return system. Residents will bring leftover, expired, and unneeded medicines to secure drop boxes in retail pharmacies or law enforcement offices throughout the county. If a drop-off site is not available in a specific area then periodic collection events or prepaid return mailers will be provided. Collected medicines are securely handled, transported and disposed of according to federal & state laws and policies. PHSKC and LHWMP provide oversight to ensure safety and compliance. 16
17 Secure Medicine Return Regulations; Drug Producers & Stewardship Plans Operation of the system by drug producers: Drug producers develop a stewardship plan to meet the requirements and standards of the Regulations. Drug Producers are the companies that manufacture the covered drug. Does not include: Compounding pharmacists preparing drugs for individual patients. Drug retail brand holders unless it is not possible to identify the manufacturer of the store brand drug. At least 167 pharmaceutical companies sell medicines for residential use in Washington State. Sales in King County alone are > $1.1 billion annually. 17
18 Secure Medicine Return Regulations: Covered Drugs Medicines accepted for return: Prescription and over-the-counter drugs from residential sources, including controlled substances. Not accepted: Over-the-counter drugs that are also regulated as cosmetics. Vitamins and supplements. Specific situations where drugs have established take-back systems. 18
19 Secure Medicine Return Regulations; Collection System Requirements Service convenience goal All pharmacies and law enforcement agencies that volunteer to serve as collectors can participate. Minimum number of drop-off sites provided or provide periodic collection events and/or prepaid mailers. Prepaid, preaddressed mailers can be requested for home bound or disabled residents. Drug handling must conform to all applicable federal and state laws, regulations, and policies, including the DEA and the Washington State Board of Pharmacy. 19
20 Overview of Secure Medicine Regulations: Final Disposal of collected medicines Disposal at a properly permitted hazardous waste facility, unless permission is granted to use a large municipal waste combustion facility (e.g. Waste-to-Energy facility) because of cost or logistical barriers. Consistent with EPA s disposal recommendations for collected household medicines (Sept. 2012). Use of alternative disposal technologies may also be approved. 20
21 Secure Medicine Return Regulations: Promotion & Evaluation Required promotion by drug producers: Promote safe storage of medicines and use of the medicine return system Materials for pharmacies, health care facilities, and others Website and toll-free number Develop clear instructions on use of secure drop boxes and a readily recognizable, consistent drop box design Required evaluation by drug producers: Annually report pounds of medicines collected & evaluate the effectiveness of program promotion Conduct survey of residents after the first program year, and again at years five and nine 21
22 Secure Medicine Return Regulations: Cost Responsibilities Drug producers are responsible for costs of: Collection supplies, prepaid mailers, collection events Transporting collected medicines and final disposal Program promotion and evaluation Administrative costs Fees to PHSKC to reimburse costs of oversight Voluntary collectors will provide in-kind staff time at drop-off sites. LHWMP will assist with start-up costs of secure drop boxes and with education/promotion. No visible fee on medicines at purchase or return. 22
23 Secure Medicine Return Regulations: Oversight & Enforcement Public Health Seattle & King County & the Local Hazardous Waste Management Program Review and approval of the stewardship plan(s), plan changes, and plan updates Monitoring of plan operations Inspections as needed Review of annual reports Enforcement: written warnings and civil penalties of up to $2,000 per day. Agency cost recovery through fees collected from each stewardship plan, paid by drug producers. 23
24 Secure Medicine Return Regulations: Key Implementation Deadlines Program start expected ~18 months from adoption of the Regulations on June 20, By December 20, 2013 Each drug producer selling covered drugs in or into King County must indicate their intent to participate in a stewardship plan. By March 20, 2014 Drug producers must notify all retail pharmacies and law enforcement agencies in the county of the opportunity to participate as a drop-off site. By June 20, 2014 Drug producers must submit a proposed stewardship plan for review. Stewardship plans must start within 3 months of approval. 24
25 Secure Medicine Return Regulations website: to receive updates subscribe to: Information & Resources on Medicine Take-back in WA & Product Stewardship:
The Future of Pharmaceutical Waste Regulation. Elise Paeffgen Senior Associate Alston & Bird LLP
The Future of Pharmaceutical Waste Regulation Elise Paeffgen Senior Associate Alston & Bird LLP Issue/Problem Pharmaceuticals in municipal drinking water Sources: Human ingestion/excretion Flushed pharmaceutical
PHARMACEUTICAL WASTE UPDATE ON HANDLING AND DISPOSAL ASTSWMO MEETING August 11, 2011
PHARMACEUTICAL WASTE UPDATE ON HANDLING AND DISPOSAL ASTSWMO MEETING August 11, 2011 Pharmaceutical Waste Getting the attention it deserves Are there Federal, State and Local laws & regulations to comply
Statement of Mary L. Hendrickson,PharmD,MBA,RAC Director of Quality & Regulatory Affairs Capital Returns Inc., d/b/a Genco Pharmaceutical Services
Statement of Mary L. Hendrickson,PharmD,MBA,RAC Director of Quality & Regulatory Affairs Capital Returns Inc., d/b/a Genco Pharmaceutical Services Before The Special Committee on Aging United States Senate
Safe Disposal of Unused Controlled Substances/
Safe Disposal of Unused Controlled Substances/ Current Challenges and Opportunities for Reform Prepared for: King Pharmaceuticals, Inc. Prepared by: Sharon Siler Suzanne Duda Ruth Brown Josette Gbemudu
Drug Take-back Programs: Safe Disposal of Unused, Expired, or Unwanted Medications in North Carolina
Drug Take-back Programs: Safe Disposal of Unused, Expired, or Unwanted Medications in North Carolina Prepared for: Coastal Coalition for Substance Abuse Prevention Prepared by: Tanya Elaine Simons 10 October,
DISPOSAL OF CONTROLLED SUBSTANCES
DISPOSAL OF CONTROLLED SUBSTANCES WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association Outline of Today s 2/2/2 PRESENTER Jan Harris Director, EHS Customer Compliance
SHARPS COLLECTION PROGRAM PLAN FOR THE PRINCE EDWARD ISLAND MEDICAL SHARP STEWARDSHIP PROGRAM
SHARPS COLLECTION PROGRAM PLAN FOR THE PRINCE EDWARD ISLAND MEDICAL SHARP STEWARDSHIP PROGRAM DECEMBER 2014 EXECUTIVE SUMMARY On June 10, 2014 Prince Edward Island approved the Environmental Protection
BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY:
BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY: About the report About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country s leading innovative
Management of Pharmaceutical Wastes from Healthcare & Households. Rudy Vingris Product Manager PharmEcology Services Waste Management, Inc.
Management of Pharmaceutical Wastes from Healthcare & Households Rudy Vingris Product Manager PharmEcology Services Waste Management, Inc. Legal Disclaimer This presentation is solely for educational purposes
Program Update: San Francisco s Safe Medicine Disposal Pilot
Edwin M. Lee Mayor Melanie Nutter Director Program Update: San Francisco s Safe Medicine Disposal Pilot Introduction: San Francisco s Safe Medicine Disposal Pilot Program has been in operation since April
Title 16. Board of Pharmacy Proposed Text
Title 16. Board of Pharmacy Proposed Text Proposal to add new Article 9.1 of Division 17 of Title 16 of the California Code of Regulations and a new Article title as follows: Article 9.1. Prescription
Pharmaceutical Waste Initiatives: What Comes Next? ACPE # 0206-0000-12-601-L05-P (0.1 CEU)
Date: Monday, August 27, 2012 Time: 10:15 a.m. 11:15 a.m. Location: Colorado Convention Center Rooms 111-113 Title: Speaker: Pharmaceutical Waste Initiatives: What Comes Next? ACPE # 0206-0000-12-601-L05-P
EPA s proposed hazardous waste pharmaceutical regulations
EPA s proposed hazardous waste pharmaceutical regulations November 4, 2015 By J. Timothy Ramsey The United States Environmental Protection Agency ( EPA ) published proposed regulations in the Federal Register
Drugs in Our Drinking Water
Drugs in Our Drinking Water What do we do with unused medicines? By Susan Q. Stranahan February 27, 2009 Photo: Getty Images Millions of Americans are drinking water laced with minute quantities of drugs,
Be it enacted by the People of the State of Illinois,
AN ACT concerning safety. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section 3. The Department of Public Health Powers and Duties Law of the Civil Administrative
Disposal of Pharmaceuticals, and their empty containers, in the Workplace
Disposal of Pharmaceuticals, and their empty containers, in the Workplace Prepared by Bio-Team Mobile LLC There is a lot of misinformation being circulated about disposal of pharmaceuticals ever since
Prescription Drug Abuse
DELAWARE DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Delaware. Delaware At-a-Glance: In 2007-2008, Delaware was one of the top
UTAH DRUG CONTROL UPDATE. Substance Abuse Treatment Admissions Data
UTAH DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Utah. Utah At-a-Glance: Approximately 6 percent of Utah residents reported past-month
OREGON DRUG CONTROL UPDATE. Drug Use Trends in Oregon
OREGON DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Oregon. Oregon At-a-Glance: In 2009-2010, Oregon was one of the top ten states
NEVADA DRUG CONTROL UPDATE. Drug Use Trends in Nevada. Substance Abuse Treatment Admissions Data
NEVADA DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Nevada. Nevada At-a-Glance: The rate of drug-induced deaths in Nevada is higher
HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR
HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 371 CS Cancer Drug Donation Program SPONSOR(S): Harrell TIED BILLS: IDEN./SIM. BILLS: SB 1310 REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care General
QUEEN ANNE S COUNTY STRATEGIC PLAN ALCOHOL AND DRUG ABUSE SERVICES
QUEEN ANNE S COUNTY STRATEGIC PLAN ALCOHOL AND DRUG ABUSE SERVICES 2016 2018 INTRODUCTION Local councils are established under Chapters 237 and 238 of the Acts of the General Assembly of Maryland of 2004,
For a Healthier America: Reducing Prescription Drug Misuse and Abuse
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy
Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace
Substance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
Sharps/Needles Informational Webinar
Household Hazardous Waste Technical Council Presents: Sharps/Needles Informational Webinar Thursday, October 8, 2015 www.hhwtc.org About the HHW Technical Council CRRA s HHW Technical Council is composed
3341-7-09 Use of Controlled Substances in Research.
3341-7-09 Use of Controlled Substances in Research. Applicability Faculty and staff who hold federal Drug Enforcement Administration (DEA) licenses to use controlled substances for research purposes. Responsible
NEW JERSEY DRUG CONTROL UPDATE. Drug Use Trends in New Jersey
NEW JERSEY DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of New Jersey. New Jersey At-a-Glance: In 2009-2010 New Jersey was one of the
VERMONT2007. Drugs and Medical Supply Repository Study. Report to the Legislature on Act 139 Sec. 6 Report Relating to 8 V.S.A. 107 January 15, 2007
VERMONT2007 Drugs and Medical Supply Repository Study Report to the Legislature on Act 139 Sec. 6 Report Relating to 8 V.S.A. 107 108 Cherry Street, PO Box 70 Burlington, VT 05402 1.802.951.1258 healthvermont.gov
DEA Washington Division Diversion Control Program
SOUTHWEST VIRGINIA PRESCRIPTION DRUG ABUSE SUMMIT DEA Washington Division Diversion Control Program Mary Johnson-Rochee Diversion Program Manager November 14, 2012 Topics: DEA s Diversion Mission How DEA
Conflicts of Interest. Disposal of Pharmaceutical Waste: What a Technician. Who is interested in proper pharmaceutical waste disposal?
Conflicts of Interest Disposal of Pharmaceutical Waste: What a Technician Should Know Presented by Michael McEvoy Pharm.D. NorthShore University HealthSystem The speaker has nothing to disclose in relation
WEST VIRGINIA DRUG CONTROL UPDATE. Drug Use Trends in West Virginia
WEST VIRGINIA DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of West Virginia. West Virginia At-a-Glance: In 2007-2008, West Virginia
Opioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
Hazardous Waste Self Audit
Section: Waste Pharmaceuticals Hazardous Waste Self Audit Section: Waste Pharmaceuticals Self-Audit Tips, Action Steps & Resources Types of pharmaceuticals Pharmaceuticals include but are not limited to:
Maximizing Organics Diversion: A Comparison of Residential Food Waste Capture Rates
Maximizing Organics Diversion: A Comparison of Residential Food Waste Capture Rates U.S. Composting Council Conference Orlando, FL January 29th, 2013 Rhodes Yepsen Outline Background on Novamont The Need
Dear Chairman Hardy, Chairman Oscarson, and Members of the Committee:
Testimony Joint Senate and Assembly Health and Human Services Committee Wednesday, April 1, 2015 3:30 p.m. SB 459 Dear Chairman Hardy, Chairman Oscarson, and Members of the Committee: My name is Linda
ORDINANCE NO. 3 OF 2009
PENN TOWNSHIP CUMBERLAND COUNTY BOARD OF SUPERVISORS 1301 Centerville Road Tel: 717-486-3104 Newville, PA 17241 Fax: 717-486-3522 Email: [email protected] Website: www.penntwpcc.org ORDINANCE NO. 3 OF
Federal Response to Opioid Abuse Epidemic
Healthcare Committee Federal Response to Opioid Abuse Epidemic On May 1, 20215 the Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled What is the Federal Government
Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED
Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED INVESTOR PRESENTATION NOVEMBER Safe Harbor These slides contain (and the accompanying oral discussion will contain)
HAWAII DRUG CONTROL UPDATE. Drug Use Trends in Hawaii. Substance Abuse Treatment Admissions Data
HAWAII DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Hawaii. Hawaii At-a-Glance: In the 2007-2008 time period, Hawaii was among the
RE: Opposition to the Los Angeles County Pharmaceuticals and Sharps Collection and Disposal Stewardship Ordinance
November 30, 2015 Pharmaceutical Working Group c/o Angelo J. Bellomo, REHS, QEP, Deputy Director for Health Protection 5050 Commerce Drive Baldwin Park, CA 91706 RE: Opposition to the Los Angeles County
The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community
The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community November 2014 INTRODUCTION The Heroin
DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS
DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS (By authority conferred on the director of the department of licensing and
Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010
Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence Service Officer Tennessee Department of
Prescription Monitoring Programs: Creating a National Network
Prescription Monitoring Programs: Creating a National Network Danna E. Droz, JD, RPH PMP Liaison [email protected] 847/391-4508 United States Drug Enforcement Administration National Conference on Pharmaceutical
National Poll: Chronic Pain and Drug Addiction
National Poll: Chronic Pain and Drug Addiction April 2013 Results of a New Public Opinion Poll National Poll on Chronic Pain and Drug Addiction The National Poll on Chronic Pain was conducted online in
Compliance Bulletin Solid Waste Medical Waste Treatment reviewed/revised February 2012
Compliance Bulletin Solid Waste Medical Waste Treatment reviewed/revised February 2012 Medical waste can be divided into two basic types for treatment purposes: 1) infectious wastes like blood and body
Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015
Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol New Mexico Pharmacists Association & Project ECHO 2014 This training fulfills the educational requirement for pharmacists in
Pharmaceutical waste disposal Guideline. Guideline for Disposal of Pharmaceutical waste (1 st Edition, 2014)
Guideline for Disposal of Pharmaceutical waste (1 st Edition, 2014) 1 Contents 1. Definition... 3 2. Principle and General Requirements... 3 3. Process flow chart... 4 4. Procedure... 5 5. Recording and
Managing Pharmaceutical Wastes: Law and Regulations
Managing Pharmaceutical Wastes: Law and Regulations James T. Price Missouri Waste Control Coalition Conference June 30, 2014 2014 WA 5625923.1 From the Missouri Department of Natural Resources Health Care:
Medicare Coverage Gap Discount Program (Filling the Donut Hole)
Medicare Coverage Gap Discount Program (Filling the Donut Hole) Summary: Requires drug manufacturers to provide a 50 percent discount to Part D beneficiaries for brand name drugs and biologics purchased
Managing Pharmaceutical Waste at the LTC Provider Pharmacy
Managing Pharmaceutical at the LTC Provider Pharmacy Is your pharmacy compliant with all regulations related to pharmaceutical waste? The long-term care (LTC) industry is currently faced with the simultaneous
Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices
Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices National Governors Association Policy Academy: Reducing Prescription Drug Abuse June 8, 2015 Burlington, VT Improving Interstate
CAPITOL research. Interstate Information Sharing: Prescription Drug Monitoring Programs
The Council of State governments CAPITOL research APRIL 00 Prescription Drug Monitoring Interstate Information Sharing: Prescription Drug Monitoring Programs The Council of State Governments Misuse of
Pharmaceutical Waste Compliance Program
Pharmaceutical Waste Compliance Program Corporate Overview Stericycle Services Medical Waste Management Sharps Disposal Management Product Recalls & Retrieval OSHA Compliance Training Pharmaceutical &
PRESCRIPTION PAINKILLER OVERDOSES
IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky
Region 8 Conference Amalgam Separators What s New? 101 Review May 11 14, 2009
Region 8 Conference Amalgam Separators What s New? 101 Review May 11 14, 2009 AL Dube National Sales Manager SolmeteX, a division of Layne Christensen ([email protected]) What s New in the Amalgam Separator
tdc Household Pharmaceutical Waste: Regulatory and Prepared for the San Francisco Department of the Environment environmental
tdc environmental Household Pharmaceutical Waste: Regulatory and.. Management.... Issues.... Prepared for the San Francisco Department of the Environment August 2004 PREFACE This is a report of research
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
Alameda County Safe Medication Disposal Initiative Assessment
Alameda County Safe Medication Disposal Initiative Assessment 2007 2014 S U B M I T T E D TO : Alameda County Health Care Services Agency P R E PA R E D BY: Joel Kreisberg Teleosis Institute 863 Arlington
INSPECTORS CHECKLIST MONITORING AND INSPECTION VISITS
INSPECTORS CHECKLIST MONITORING AND INSPECTION VISITS About this document This document is a guide to show what the Inspectorate may look for during an inspection visit. It is intended for use by the GPhC
Fraud, Waste and Abuse Network Pharmacy Training 2011
Fraud, Waste and Abuse Network Pharmacy Training 2011 Table of Contents Centers for Medicare & Medicaid Services (CMS) Role Important Federal Statutes for Medicare Participants Fraud, Waste and Abuse Defined
Pennsylvania s ABC-MAP Program
Pennsylvania s ABC-MAP Program Recommendations on Best Practices ABC-MAP Governance Board Meeting May 20, 2015 Brandon C. Maughan, MD, MHS Marcus A. Bachhuber, MD University of Pennsylvania Philadelphia
Center for Lawful Access and Abuse Deterrence 9/8/2014
ASPMN 24 th National Conference San Diego, CA September 17 20, 2014 Addressing an Evolving Epidemic Through Substance Use Intervention and Treatment Policies Michael C. Barnes Executive Director Conflict
An Introduction to Product Takeback
An Introduction to Product Takeback Overview Driving forces behind product takeback Product takeback legislation Product end-of-life options Reverse logistics Case study Motivation for Product Takeback
IV. ENVIRONMENTAL IMPACT ANALYSIS L. UTILITIES AND SERVICE SYSTEMS 3. SOLID WASTE AND DISPOSAL
IV. ENVIRONMENTAL IMPACT ANALYSIS L. UTILITIES AND SERVICE SYSTEMS 3. SOLID WASTE AND DISPOSAL ENVIRONMENTAL SETTING Within the City, solid waste management, including collection and disposal services
RCRA Applied to Retail and Pharmaceutical Wastes, How to Manage a Work in Progress. Gregory W. Blount Troutman Sanders LLP Atlanta, GA
RCRA Applied to Retail and Pharmaceutical Wastes, How to Manage a Work in Progress Gregory W. Blount Troutman Sanders LLP Atlanta, GA TABLE OF CONTENTS INTRODUCTION... 1 A. Determining Whether a Pharmaceutical
SOUTH CAROLINA DRUG CONTROL UPDATE. Drug Use Trends in South Carolina
SOUTH CAROLINA DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of South Carolina. South Carolina At-a-Glance: The number of meth lab seizure
